$YSG

Transcript: Yatsen Holding Q1 2026 Earnings Conference Call - Yatsen Holding (NYSE:YSG)

Yatsen Holding reported Q1 2026 results on a conference call. The company said total net revenues rose 22.5% year over year to $1.02 billion, driven by a 58.5% increase from skincare brands, partially offset by a 5% decline in COVID cosmetics. Gross profit rose 24.3% to $819.2 million; gross margin increased to 80.2%. Operating expenses rose 32.5% to $918.1 million, with selling and marketing up to $737.2 million. The company also said it completed a May 21, 2026 closing of a convertible notes/w

Original reporting
Published May 26, 2026, 1:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 1:45 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Transcript: Yatsen Holding Q1 2026 Earnings Conference Call - Yatsen Holding (NYSE:YSG) — source image
Decision brief

The 30-second read

$YSGBullishHigh
01

Why it matters

Key trading signals are (1) strong net revenue growth led by skincare, (2) gross margin expansion, (3) higher selling/marketing and total operating expense ratios, and (4) reduced financing overhang due to completion of the May 21 private placement change.

02

Market read

For traders, the mix of accelerating skincare growth and improving gross margin is constructive, while rising operating expense intensity is the main counterweight.

03

What to watch

The call emphasizes gross margin and skincare growth, but does not quantify net income/operating profit in the excerpt; investors may wait for full cost breakdown and guidance details beyond the transcript.

Relevance 9/10Timing: Immediate catalyst: Q1 2026 earnings transcript with disclosed financial metrics and financing closing on May 21, 2026.

Background

The article is a transcript of Yatsen Holding’s Q1 2026 earnings conference call, covering performance drivers (multi-brand strategy, skincare momentum), cost structure, and a recent convertible notes/warrants financing closing.

Company-level read

Ticker impact

$YSGBullishMedium confidence
Context

Yatsen Holding reported Q1 2026 revenue +22.5% YoY, margin expansion to 80.2%, and completed a May 21 convertible notes/warrants placement.

Expected impact

Likely near-term positive bias on the stock from revenue/margin beats and financing completion, tempered by higher operating expense intensity.

Evidence & confidence

The transcript provides multiple directional KPIs (net revenue +22.5%, gross margin +110 bps, operating expense ratio up) and confirms a completed financing closing, which typically supports liquidity/financing overhang expectations.

Market effects

Beauty/skin-care peers may see read-across on channel economics (Douyin traffic acquisition costs) and margin sensitivity to marketing intensity.

China domestic beauty demand appears resilient but highly competitive, with online growth described as single-digit YoY.

Limited direct global spillover mentioned beyond brand activity and congress participation; focus remains on China channel performance.

Counterpoint

Operating expenses rose 32.5% and the operating expense ratio worsened (89.9% vs 83.2%), so margin gains may not translate into sustainable operating leverage if marketing costs stay elevated.

Key entities

  • Yatsen Holding

    Reported Q1 2026 results and confirmed completion of the May 21 convertible notes/warrants transaction.

Related articles

$CNRHighAI 8/10

RBC Capital Names Top 30 Global Stock Ideas for 2026

RBC Capital updated its Top 30 Global Ideas list for 2026, adding Apotex Health, Canadian National Railway (CNR), and Lonza (LONN). The list delivered an 11.1% return in Q2/26. CNR reported Q2/26 earnings of C$2.08 per share on $4.75B revenue, raising its full-year guidance. RBC highlights CNR's discount valuation, Apotex's market share, and Lonza's growth potential.

$PLABHigh

Why Photronics' Stock Briefly Soared 27% This Morning

Photronics (PLAB) reported fiscal Q3 2026 earnings beating expectations with $216.0M revenue and $0.50 EPS, causing a 27.1% stock surge. However, shares later cooled to a 4% gain due to modest year-over-year growth and guidance. The company's high-end IC work reached a record 44% of total IC revenue, but orders are affected by product delays and geopolitical uncertainty.

$COSTHighAI 8/10

Costco Has a Secret Growth Engine. Wall Street May Be Underestimating It.

Costco (COST) receives a BUY rating with a $1,024 price target, driven by a 92% membership renewal rate and 22% digital sales growth. The company reported Q3 EPS of $4.93 on $70.53B revenue, with membership fee income up 10.7%. Costco trades at 48x earnings, and analysts highlight risks like valuation and membership growth deceleration. Comparisons with Walmart (WMT) and BJ's Wholesale (BJ) emphasize Costco's premium multiple.

$TGTHighAI 9/10

Target (TGT) Q2 2026 Earnings Call Transcript

Target (TGT) reported Q2 2026 net sales of $26.5B, up 5.3% YoY, with EPS of $4.11, a 100% increase due to tariff refunds. Digital sales rose 8.7%, while store sales grew 2.7%. The company raised full-year guidance, expecting 5% sales growth and EPS of $9.90-$10.90. Management highlighted growth in snacks, beauty, and digital traffic, but noted challenges in home and apparel categories.